1. Market Research
About 300 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Vaginal Cancer - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 381 pages

Vaginal Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer – Pipeline Review, H1 2020, provides an overview of the Vaginal Cance ...

  • Lung Cancer
  • Sexually Transmitted Disease
  • Therapy
  • North America
  • United States

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 403 pages

Aspirin and Rintatolimod With or Without Interferon-alpha ##b in Treating Patients with Prostate Cancer Before Surgery (NCT NCT## - authorized by the FDA and Roswell Park s Internal Review Board; not yet recruiting), and Chemokine Modulation Therapy and Pembrolizumab in Treating Partic

  • Lung Cancer
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • United States

Vaginal Cancer - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 351 pages

Aspirin and Rintatolimod With or Without Interferon-alpha ##b in Treating Patients with Prostate Cancer Before Surgery (NCT NCT## - authorized by the FDA and Roswell Park s Internal Review Board; not yet recruiting), and Chemokine Modulation Therapy and Pembrolizumab in Treating Partic

  • Cancer
  • Lung Cancer
  • Salicylic Acid
  • North America
  • United States

Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 145 pages

Studies have demonstrated that pre-treating with aspirin ## minutes before fumarate dosing can significantly reduce flush.

  • Hospital
  • Neurological Disorder
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

Hypercholesterolemia - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 252 pages

ASPIRIN + LISINOPRIL + LOVASTATIN) - DRUG PROFILE (ASPIRIN + LISINOPRIL + LOVASTATIN) (ATORVASTATIN + EZETIMIBE) - DRUG PROFILE (OLMESARTAN MEDOXOMIL + ROSUVASTATIN CALCIUM) - DRUG PROFILE (OLMESARTAN MEDOXOMIL + ROSUVASTATIN CALCIUM) STOCOSIL INC NA Drug Name Company / Institu

  • Cardiovascular Disease
  • Lipid Modifying Drug
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

Aminopeptidase N - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 58 pages

MAR ##, 2018: FIRST SUBJECT ENROLLED IN PHASE I CLINICAL TRIAL OF ITS NON-OPIOID ANALGESIC STR-## The Stragen group announced the enrollment of the first subject to participate in a Phase I study of STR-##, a first in the class of non-opioid analgesic.

  • Endocrine Disease
  • Salicylic Acid
  • Therapy
  • United States
  • MolMed S.p.A.

Glycogen Synthase Kinase 3 Beta - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 69 pages

IB-AD - DRUG PROFILE LITHIUM SALICYLATE - DRUG PROFILE acid and L-proline (LISPRO).

  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Product Initiative
  • AMO Pharma

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H1 2018

  • $ 3500
  • April 2018
  • 59 pages

NON-OPIOID ANALGESIC STR-## The Stragen group announced the enrollment of the first subject to participate in a Phase I study of STR-##, a first in the class of non-opioid analgesic.

  • Cardiovascular Disease
  • Heart Failure
  • Hospital
  • Therapy
  • Novartis AG

Myocardial Infarction - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 362 pages

OTITOPIC IS DEVELOPING ASPIRIN (OTI-##).

  • Chronic Disease
  • Heart Attack
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

Gaucher Disease - Pipeline Review, H1 2020

  • $ 2000
  • June 2020
  • 105 pages

Gaucher Disease - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Pipeline Review, H1 2020, provides an overview of the Gaucher Disease ...

  • Gene Therapy
  • Pathology
  • Psychotic Disorder
  • Therapy
  • Genzyme Corporation

Medestea Research & Production S.p.A. - Product Pipeline Review - 2016

  • $ 1500
  • September 2016
  • 34 pages

The drug candidate is a type of aspirin.

  • HIV AIDS
  • Salicylic Acid
  • Therapy
  • Italy
  • Supply

Plague - Pipeline Review, H1 2020

  • $ 2000
  • January 2020
  • 70 pages

Plague - Pipeline Review, H## 2020 Reference Code: GMDHC##IDB Publication Date: January 2020 LIST OF TABLES Introduction GLOBAL MARKETS DIRECT REPORT COVERAGE Global Markets Direct' s, ' Plague - Pipeline Review, H## 2020', provides an overview of the Plague pipeline landscape.

  • Infectious Disease
  • Therapy
  • Vaccine
  • United States
  • Achaogen, Inc.

Thromboembolism - Pipeline Review, H2 2019

  • $ 2000
  • August 2019
  • 111 pages

Similarly, within the population of patients with CAD, the combination of rivaroxaban vascular dose plus aspirin also reduced the risk of the primary endpoint of MACE compared to aspirin alone.

  • Cardiovascular Disease
  • Hospital
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

Plague - Pipeline Review, H2 2019

  • $ 2000
  • September 2019
  • 67 pages

Plague - Pipeline Review, H## 2019 Reference Code: GMDHC##IDB Publication Date: September 2019 LIST OF TABLES Introduction GLOBAL MARKETS DIRECT REPORT COVERAGE Global Markets Direct' s, ' Plague - Pipeline Review, H## 2019', provides an overview of the Plague pipeline landscape.

  • Infectious Disease
  • Therapy
  • Vaccine
  • United States
  • Achaogen, Inc.

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 58 pages

MAR ##, 2018: FIRST SUBJECT ENROLLED IN PHASE I CLINICAL TRIAL OF ITS NON-OPIOID ANALGESIC STR-## THE STRAGEN GROUP ANNOUNCED THE ENROLLMENT OF THE FIRST SUBJECT TO PARTICIPATE IN A PHASE I STUDY OF STR-##, A FIRST IN THE CLASS OF NON-OPIOID ANALGESIC.

  • Cardiovascular Disease
  • Heart Failure
  • Hospital
  • Therapy
  • Novartis AG

Thromboembolism - Pipeline Review, H1 2020

  • $ 2000
  • January 2020
  • 127 pages

Similarly, within the population of patients with CAD, the combination of rivaroxaban vascular dose plus aspirin also reduced the risk of the primary endpoint of MACE compared to aspirin alone.

  • Cardiovascular Disease
  • Hospital
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

Sepsis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 367 pages

PHYSOSTIGMINE SALICYLATE - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner PHYSOSTIGMINE SALICYLATE DR.

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

Arterial Thrombosis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 58 pages

Arterial Thrombosis - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis - Pipeline Review, H2 2019, provides an overview of the Arterial ...

  • Blood Disease
  • Pathology
  • Therapy
  • United States
  • XBiotech Inc.

Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 83 pages

The second group will take clopidogrel and aspirin the first month, and then they will be on aspirin alone for months two through six.

  • Blood Disease
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • AstraZeneca PLC

Gaucher Disease - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 95 pages

Gaucher Disease - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Pipeline Review, H2 2019, provides an overview of the Gaucher Disease ...

  • Pathology
  • Pharmaceutical
  • Psychotic Disorder
  • Therapy
  • Genzyme Corporation
View report >

Hospital Social Impact in Texas (USA)

  • January 2019
  • 70 pages

OF ##, ## MI CASES SEEN BETWEEN 2008 AND 2018, ##. ##% WERE PRESCRIBED ASPIRIN WITHIN THE FIRST ## HOURS OF EITHER FIRST MEDICAL CONTACT OR HOSPITAL ARRIVAL, ##. ##% WERE NOT PRESCRIBED ASPIRIN, AND ##. ##% HAD CONTRAINDICATIONS TO ASPIRIN USE (PG. ##).

  • Health Services
  • Heart Attack
  • Hospital
  • Salicylic Acid
  • United States

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on